ARS Pharmaceuticals Inc (SPRY) Straddle

Trading a SPRY straddle lets you take a pure volatility position on ARS Pharmaceuticals Inc without committing to a direction. ARS Pharmaceuticals Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate SPRY straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on SPRY profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when ARS Pharmaceuticals Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the SPRY straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the SPRY straddle is the cleanest expression of that view. Our scanner prices every SPRY straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a SPRY straddle into a catalyst or short a SPRY straddle to harvest decay, the options straddle setups that matter are all in one place.